Items where Author is "Rahimmanesh, I."

Article

(2025) Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology-based strategies for enhanced CAR T/NK cell therapy. Bioengineering & translational medicine. e10716. ISSN 2380-6761 (Print) 2380-6761 (Electronic) 2380-6761 (Linking)

(2024) Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine. International Immunopharmacology. p. 10. ISSN 1567-5769

(2024) Exploring metal-organic frameworks in gene delivery: From prostate to lung therapeutics. Applied Materials Today. p. 19. ISSN 2352-9407

(2024) Novel SARS-COV2 poly epitope phage-based candidate vaccine and its immunogenicity. Research in Pharmaceutical Sciences. pp. 573-590. ISSN 1735-5362

(2024) Prospective Prediction of Treatment Response in High-Grade Glioma Patients using Pre-Treatment Tumor ADC Value and miR-222 and miR-205 Expression Levels in Plasma. Journal of biomedical physics & engineering. pp. 111-118. ISSN 2251-7200 (Print) 2251-7200 (Electronic) 2251-7200 (Linking)

(2024) Smart co-delivery of plasmid DNA and doxorubicin using MCM-chitosan-PEG polymerization functionalized with MUC-1 aptamer against breast cancer. Biomedicine & Pharmacotherapy. p. 15. ISSN 0753-3322

(2023) Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering. Environmental Research. p. 18. ISSN 0013-9351

(2023) Crosstalk of Transcriptional Regulators of Adaptive Immune System and microRNAs: An Insight into Differentiation and Development. Cells. p. 23.

(2023) Enhanced in vivo anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody. Research in Pharmaceutical Sciences. pp. 138-148. ISSN 1735-5362 (Print) 1735-9414 (Electronic) 1735-5362 (Linking)

(2023) Enhanced<i> in</i><i> vivo</i> anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody. Research in Pharmaceutical Sciences. pp. 138-148. ISSN 1735-5362

(2023) Phage based vaccine: A novel strategy in prevention and treatment. Heliyon. p. 17.

(2023) A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma. European Journal of Pharmaceutical Sciences. p. 21. ISSN 0928-0987

(2023) miRNA-encapsulated abiotic materials and biovectors for cutaneous and oral wound healing: Biogenesis, mechanisms, and delivery nanocarriers. Bioengineering & translational medicine. e10343. ISSN 2380-6761 (Print) 2380-6761 (Electronic) 2380-6761 (Linking)

(2023) The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy. Environmental Research. p. 17. ISSN 0013-9351

(2023) The nexus of natural killer cells and melanoma tumor microenvironment: crosstalk, chemotherapeutic potential, and innovative NK cell-based therapeutic strategies. Cancer Cell International. p. 20.

(2022) Advances in aptamer-based drug delivery vehicles for cancer therapy. Biomater Adv. p. 213077. ISSN 2772-9508

(2022) Cancer Occurrence as the Upcoming Complications of COVID-19. FRONTIERS IN MOLECULAR BIOSCIENCES. ISSN 2296-889X J9 - FRONT MOL BIOSCI

(2022) Cancer Occurrence as the Upcoming Complications of COVID-19. Frontiers in Molecular Biosciences. ISSN 2296889X (ISSN)

(2022) Conceptual framework for SARS-CoV-2-related lymphopenia. ADVANCED BIOMEDICAL RESEARCH. ISSN 2277-9175 J9 - ADV BIOMED RES-INDIA

(2022) Gene Editing-Based Technologies for <i>Beta-hemoglobinopathies</i> Treatment. Biology-Basel. p. 19.

(2022) Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment. BIOLOGY-BASEL. ISSN 2079-7737 J9 - BIOLOGY-BASEL

(2022) Genetically Engineered Viral Vectors and Organic-Based Non-Viral Nanocarriers for Drug Delivery Applications. Adv Healthc Mater. e2201583. ISSN 2192-2640

(2022) Genetically Engineered Viral Vectors and Organic-Based Non-Viral Nanocarriers for Drug Delivery Applications. Advanced Healthcare Materials. p. 31. ISSN 2192-2640

(2022) Identification of significant genes and pathways associated with tenascin-C in cancer progression by bioinformatics analysis. ADVANCED BIOMEDICAL RESEARCH. ISSN 2277-9175 J9 - ADV BIOMED RES-INDIA

(2022) Nucleic acid-based therapeutics for dermal wound healing. Int J Biol Macromol. pp. 920-933. ISSN 0141-8130

(2022) Optimization of culture media for ex vivo T-cell expansion for adoptive T-cell therapy. Advanced Biomedical Research. p. 6. ISSN 2277-9175

(2021) Cancer Occurrence as the Upcoming Complications of COVID-19. Front Mol Biosci. p. 813175. ISSN 2296-889X (Print) 2296-889x

(2021) Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer. RESEARCH IN PHARMACEUTICAL SCIENCES. pp. 447-454. ISSN 1735-5362 1735-9414 J9 - RES PHARM SCI

(2021) Generation of HBsAg DNA aptamer using modified cell-based SELEX strategy. Molecular Biology Reports. pp. 139-146. ISSN 0301-4851

(2021) The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy. International Journal of Molecular Sciences.

(2016) Expression of biologically active murine interleukin-18 in Lactococcus lactis. Fems Microbiology Letters. ISSN 0378-1097

(2016) Genetic disruption of the KLF1 gene to overexpress the -globin gene using the CRISPR/Cas9 system. Journal of Gene Medicine. pp. 294-301. ISSN 1099-498X

(2015) Development of a Stable Cell Line, Overexpressing Human T-cell Immunoglobulin Mucin 1. Iranian Journal of Biotechnology. pp. 25-31. ISSN 1728-3043